Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I McFarlane

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Insulin resistance and cardiovascular diseaseS I McFarlane, M Banerji, J R Sowers
Current Diabetes Reports|July 16, 2008
What are the long-term cardiovascular effects of treatment with rosiglitazone?Fiby Nessim, Lisel Loney-Hutchinson, Samy I McFarlane
Cureus|July 13, 2022
Duplication of AKT2 Gene in Ovarian Cancer: A Potentially Novel Mechanism for Tumor-Induced HypoglycemiaHussam R Alkaissi, Zachary Mostel, Samy I McFarlane
Vascular Medicine (London, England)|April 18, 2002
Vascular complications in diabetes and their preventionE Kassab, S I McFarlane, J R Sower
Epidemiology (Sunnyvale, Calif.)|August 2, 2016
Sleep Disorders and Cardio-Renal Disease: Implications for Minority PopulationsJudith Giunta, Moro O Salifu, Samy I McFarlane
Journal of Cardiac Failure|September 19, 2003
Heart failure in diabetic patients: utility of beta-blockadeDmitri Kirpichnikov, Samy I McFarlane, James R Sowers
Archives of Internal Medicine|December 10, 2003
Role of the natriuretic peptide system in cardiorenal protectionSamy I McFarlane, Nathaniel Winer, James R Sowers
Current Diabetes Reports|June 4, 2009
ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risksHoWon Lee, Amgad N Makaryus, Samy I McFarlane
The American Journal of Cardiology|June 24, 2003
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular diseaseSamy I McFarlane, Ashok Kumar, James R Sowers
Current Diabetes Reports|June 4, 2009
Treatment of hypertension in metabolic syndrome: implications of recent clinical trialsAmgad N Makaryus, Philippe Akhrass, Samy I McFarlane
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Insulin resistance and cardiovascular diseaseS I McFarlane, M Banerji, J R Sowers
Current Diabetes Reports|July 16, 2008
What are the long-term cardiovascular effects of treatment with rosiglitazone?Fiby Nessim, Lisel Loney-Hutchinson, Samy I McFarlane
Cureus|July 13, 2022
Duplication of AKT2 Gene in Ovarian Cancer: A Potentially Novel Mechanism for Tumor-Induced HypoglycemiaHussam R Alkaissi, Zachary Mostel, Samy I McFarlane
Vascular Medicine (London, England)|April 18, 2002
Vascular complications in diabetes and their preventionE Kassab, S I McFarlane, J R Sower
Epidemiology (Sunnyvale, Calif.)|August 2, 2016
Sleep Disorders and Cardio-Renal Disease: Implications for Minority PopulationsJudith Giunta, Moro O Salifu, Samy I McFarlane
Journal of Cardiac Failure|September 19, 2003
Heart failure in diabetic patients: utility of beta-blockadeDmitri Kirpichnikov, Samy I McFarlane, James R Sowers
Archives of Internal Medicine|December 10, 2003
Role of the natriuretic peptide system in cardiorenal protectionSamy I McFarlane, Nathaniel Winer, James R Sowers
Current Diabetes Reports|June 4, 2009
ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risksHoWon Lee, Amgad N Makaryus, Samy I McFarlane
The American Journal of Cardiology|June 24, 2003
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular diseaseSamy I McFarlane, Ashok Kumar, James R Sowers
Current Diabetes Reports|June 4, 2009
Treatment of hypertension in metabolic syndrome: implications of recent clinical trialsAmgad N Makaryus, Philippe Akhrass, Samy I McFarlane
Pageof 24